Related references
Note: Only part of the references are listed.Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations
Rakshit S. Tanna et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2021)
Pharmacokinetics of Eleven Kratom Alkaloids Following an Oral Dose of Either Traditional or Commercial Kratom Products in Rats
Shyam H. Kamble et al.
JOURNAL OF NATURAL PRODUCTS (2021)
Investigation of the Adrenergic and Opioid Binding Affinities, Metabolic Stability, Plasma Protein Binding Properties, and Functional Effects of Selected lndole-Based Kratom Alkaloids
Samuel Obeng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Drug and Opioid-Involved Overdose Deaths - United States, 2017-2018
Nana Wilson et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Generational trends in US opioid-overdose deaths
Wayne Hall et al.
NATURE MEDICINE (2020)
A New Data Repository for Pharmacokinetic Natural Product-Drug Interactions: From Chemical Characterization to Clinical Studies
Caroline Birer-Williams et al.
DRUG METABOLISM AND DISPOSITION (2020)
The Chemistry of Kratom [Mitragyna speciosa]: Updated Characterization Data and Methods to Elucidate Indole and Oxindole Alkaloids
Laura Flores-Bocanegra et al.
JOURNAL OF NATURAL PRODUCTS (2020)
Pharmacokinetics and Safety of Mitragynine in Beagle Dogs
Elizabeth A. Maxwell et al.
PLANTA MEDICA (2020)
Metabolism of a Kratom Alkaloid Metabolite in Human Plasma Increases Its Opioid Potency and Efficacy
Shyam H. Kamble et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions
D. A. Todd et al.
SCIENTIFIC REPORTS (2020)
Unintentional Drug Overdose Deaths with Kratom Detected-27 States, July 2016-December 2017
Emily O'Malley Olsen et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
7-Hydroxymitragynine Is an Active Metabolite of Mitragynine and a Key Mediator of Its Analgesic Effects
Andrew C. Kruegel et al.
ACS CENTRAL SCIENCE (2019)
Global patterns of opioid use and dependence: harms to populations, interventions, and future action
Louisa Degenhardt et al.
LANCET (2019)
Comparative Pharmacokinetics of Mitragynine after Oral Administration of Mitragyna speciosa (Kratom) Leaf Extracts in Rats
Bonnie A. Avery et al.
PLANTA MEDICA (2019)
Metabolite profiling and identification of enzymes responsible for the metabolism of mitragynine, the major alkaloid of Mitragyna speciosa (kratom)
Shyam H. Kamble et al.
XENOBIOTICA (2019)
Selection and characterization of botanical natural products for research studies: a NaPDI center recommended approach
Joshua J. Kellogg et al.
NATURAL PRODUCT REPORTS (2019)
From Kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction
Zurina Hassan et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2013)
The Operational Multiple Dosing Half-life: A Key to Defining Drug Accumulation in Patients and to Designing Extended Release Dosage Forms
Selma Sahin et al.
PHARMACEUTICAL RESEARCH (2008)
The use of Mitragynine speciosa (Krathom), an addictive plant, in Thailand
Sawitri Assanangkornchai et al.
SUBSTANCE USE & MISUSE (2007)
Antinociceptive effect of 7-hydroxymitragynine in mice:: Discovery of an orally active opioid analgesic from the Thai medicinal herb Mitragyna speciosa
K Matsumoto et al.
LIFE SCIENCES (2004)
Chemistry and pharmacology of analgesic indole alkaloids from the rubiaceous plant, Mitragyna speciosa
H Takayama
CHEMICAL & PHARMACEUTICAL BULLETIN (2004)
Harmonized guidelines for single-laboratory validation of methods of analysis - (IUPAC technical report)
M Thompson et al.
PURE AND APPLIED CHEMISTRY (2002)
Share Paper
